NANO-X IMAGING LTD (NNOX) Fundamental Analysis & Valuation

NASDAQ:NNOX • IL0011681371

Current stock price

1.71 USD
-0.09 (-5%)
At close:
1.72 USD
+0.01 (+0.58%)
Pre-Market:

This NNOX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. NNOX Profitability Analysis

1.1 Basic Checks

  • NNOX had negative earnings in the past year.
  • In the past year NNOX has reported a negative cash flow from operations.
  • In the past 5 years NNOX always reported negative net income.
  • NNOX had a negative operating cash flow in each of the past 5 years.
NNOX Yearly Net Income VS EBIT VS OCF VS FCFNNOX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 -20M -40M -60M -80M -100M

1.2 Ratios

  • NNOX has a Return On Assets of -46.26%. This is amonst the worse of the industry: NNOX underperforms 88.00% of its industry peers.
  • With a Return On Equity value of -53.69%, NNOX is not doing good in the industry: 71.00% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -46.26%
ROE -53.69%
ROIC N/A
ROA(3y)-33.18%
ROA(5y)-32.23%
ROE(3y)-37.69%
ROE(5y)-37.3%
ROIC(3y)N/A
ROIC(5y)N/A
NNOX Yearly ROA, ROE, ROICNNOX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 0 100 -100 200

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for NNOX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NNOX Yearly Profit, Operating, Gross MarginsNNOX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 -1K -2K -3K -4K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. NNOX Health Analysis

2.1 Basic Checks

  • NNOX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, NNOX has more shares outstanding
  • NNOX has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for NNOX is higher compared to a year ago.
NNOX Yearly Shares OutstandingNNOX Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
NNOX Yearly Total Debt VS Total AssetsNNOX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.2 Solvency

  • NNOX has an Altman-Z score of -1.49. This is a bad value and indicates that NNOX is not financially healthy and even has some risk of bankruptcy.
  • NNOX's Altman-Z score of -1.49 is on the low side compared to the rest of the industry. NNOX is outperformed by 84.00% of its industry peers.
  • NNOX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -1.49
ROIC/WACCN/A
WACC8.4%
NNOX Yearly LT Debt VS Equity VS FCFNNOX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M

2.3 Liquidity

  • A Current Ratio of 3.96 indicates that NNOX has no problem at all paying its short term obligations.
  • NNOX has a better Current ratio (3.96) than 90.00% of its industry peers.
  • NNOX has a Quick Ratio of 3.77. This indicates that NNOX is financially healthy and has no problem in meeting its short term obligations.
  • NNOX's Quick ratio of 3.77 is amongst the best of the industry. NNOX outperforms 90.00% of its industry peers.
Industry RankSector Rank
Current Ratio 3.96
Quick Ratio 3.77
NNOX Yearly Current Assets VS Current LiabilitesNNOX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. NNOX Growth Analysis

3.1 Past

  • NNOX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -40.24%.
  • Looking at the last year, NNOX shows a quite strong growth in Revenue. The Revenue has grown by 15.40% in the last year.
  • NNOX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.92% yearly.
EPS 1Y (TTM)-40.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-117.39%
Revenue 1Y (TTM)15.4%
Revenue growth 3Y14.92%
Revenue growth 5YN/A
Sales Q2Q%23.97%

3.2 Future

  • The Earnings Per Share is expected to grow by 25.85% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, NNOX will show a very strong growth in Revenue. The Revenue will grow by 85.20% on average per year.
EPS Next Y54.99%
EPS Next 2Y31.59%
EPS Next 3Y34.45%
EPS Next 5Y25.85%
Revenue Next Year137.69%
Revenue Next 2Y107.49%
Revenue Next 3Y107.82%
Revenue Next 5Y85.2%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NNOX Yearly Revenue VS EstimatesNNOX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M
NNOX Yearly EPS VS EstimatesNNOX Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 1 -1 2 3

More info and screens

Find the best growth stocksShow best growing peers

1

4. NNOX Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for NNOX. In the last year negative earnings were reported.
  • Also next year NNOX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NNOX Price Earnings VS Forward Price EarningsNNOX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NNOX Per share dataNNOX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

  • NNOX's earnings are expected to grow with 34.45% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y31.59%
EPS Next 3Y34.45%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. NNOX Dividend Analysis

5.1 Amount

  • No dividends for NNOX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

NNOX Fundamentals: All Metrics, Ratios and Statistics

NANO-X IMAGING LTD

NASDAQ:NNOX (4/29/2026, 8:00:01 PM)

Premarket: 1.72 +0.01 (+0.58%)

1.71

-0.09 (-5%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Industry StrengthN/A
Industry GrowthN/A
Earnings (Last)04-20
Earnings (Next)05-27
Inst Owners24.71%
Inst Owner Change-0.06%
Ins Owners0.27%
Ins Owner Change0%
Market Cap118.35M
Revenue(TTM)13.02M
Net Income(TTM)-75.02M
Analysts84
Price Target6.78 (296.49%)
Short Float %14.75%
Short Ratio7.76
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-75.58%
Min EPS beat(2)-154.65%
Max EPS beat(2)3.49%
EPS beat(4)1
Avg EPS beat(4)-44.2%
Min EPS beat(4)-154.65%
Max EPS beat(4)3.49%
EPS beat(8)4
Avg EPS beat(8)-15.92%
EPS beat(12)6
Avg EPS beat(12)-6.7%
EPS beat(16)7
Avg EPS beat(16)-16%
Revenue beat(2)0
Avg Revenue beat(2)-6.12%
Min Revenue beat(2)-8.71%
Max Revenue beat(2)-3.53%
Revenue beat(4)0
Avg Revenue beat(4)-12.48%
Min Revenue beat(4)-30.68%
Max Revenue beat(4)-3.53%
Revenue beat(8)0
Avg Revenue beat(8)-20.54%
Revenue beat(12)0
Avg Revenue beat(12)-20.35%
Revenue beat(16)0
Avg Revenue beat(16)-19.62%
PT rev (1m)0%
PT rev (3m)-9.2%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0.98%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 9.09
P/FCF N/A
P/OCF N/A
P/B 0.85
P/tB 1.49
EV/EBITDA N/A
EPS(TTM)-1.15
EYN/A
EPS(NY)-0.52
Fwd EYN/A
FCF(TTM)-0.65
FCFYN/A
OCF(TTM)-0.59
OCFYN/A
SpS0.19
BVpS2.02
TBVpS1.15
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -46.26%
ROE -53.69%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-33.18%
ROA(5y)-32.23%
ROE(3y)-37.69%
ROE(5y)-37.3%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 35.97%
Cap/Sales 32.31%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.96
Quick Ratio 3.77
Altman-Z -1.49
F-Score3
WACC8.4%
ROIC/WACCN/A
Cap/Depr(3y)29.17%
Cap/Depr(5y)232.22%
Cap/Sales(3y)30.06%
Cap/Sales(5y)391.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-40.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-117.39%
EPS Next Y54.99%
EPS Next 2Y31.59%
EPS Next 3Y34.45%
EPS Next 5Y25.85%
Revenue 1Y (TTM)15.4%
Revenue growth 3Y14.92%
Revenue growth 5YN/A
Sales Q2Q%23.97%
Revenue Next Year137.69%
Revenue Next 2Y107.49%
Revenue Next 3Y107.82%
Revenue Next 5Y85.2%
EBIT growth 1Y-7.16%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-14.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-11.46%
OCF growth 3YN/A
OCF growth 5YN/A

NANO-X IMAGING LTD / NNOX Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for NANO-X IMAGING LTD?

ChartMill assigns a fundamental rating of 3 / 10 to NNOX.


What is the valuation status for NNOX stock?

ChartMill assigns a valuation rating of 1 / 10 to NANO-X IMAGING LTD (NNOX). This can be considered as Overvalued.


Can you provide the profitability details for NANO-X IMAGING LTD?

NANO-X IMAGING LTD (NNOX) has a profitability rating of 0 / 10.


Can you provide the financial health for NNOX stock?

The financial health rating of NANO-X IMAGING LTD (NNOX) is 6 / 10.